1-4 of 4
Kathleen Lamborn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

Monica E. Loghin, Michael D. Prados, Patrick Wen, Larry Junck, Frank Lieberman, Howard Fine, Karen L. Fink, Minesh Metha, John Kuhn, Kathleen Lamborn, Susan M. Chang, Timothy Cloughesy, Lisa M. DeAngelis, Ian H. Robins, Kenneth D. Aldape, W.K. Alfred Yung
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (23): 7133–7138.
https://doi.org/10.1158/1078-0432.CCR-07-0874
Published: 03 December 2007
View article titled, Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study
Open the PDF for Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study in another window
Journal Articles

Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01

Andrew B. Lassman, Michael R. Rossi, Jeffrey R. Razier, Lauren E. Abrey, Frank S. Lieberman, Chelsea N. Grefe, Kathleen Lamborn, William Pao, Alan H. Shih, John G. Kuhn, Richard Wilson, Norma J. Nowak, John K. Cowell, Lisa M. DeAngelis, Patrick Wen, Mark R. Gilbert, Susan Chang, W.A. Yung, Michael Prados, Eric C. Holland
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7841–7850.
https://doi.org/10.1158/1078-0432.CCR-05-0421
Published: 08 November 2005
View article titled, Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Open the PDF for Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 in another window
Includes: Supplementary data
Journal Articles

Does Paclitaxel (Taxol) Given after 111In-Labeled Monoclonal Antibodies Increase Tumor-Cumulated Activity in Epithelial Cancers?

Laird Miers, Kathleen Lamborn, Aina Yuan, Carol Richman, Arutselvan Natarajan, Sally DeNardo, Gerald DeNardo
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7158s–7163s.
https://doi.org/10.1158/1078-0432.CCR-1004-0012
Published: 03 October 2005
View article titled, Does Paclitaxel (Taxol) Given after <sup>111</sup>In-Labeled Monoclonal Antibodies Increase Tumor-Cumulated Activity in Epithelial Cancers?
Open the PDF for Does Paclitaxel (Taxol) Given after <sup>111</sup>In-Labeled Monoclonal Antibodies Increase Tumor-Cumulated Activity in Epithelial Cancers? in another window
Journal Articles

Chromosomal Abnormalities in Glioblastoma Multiforme by Comparative Genomic Hybridization: Correlation with Radiation Treatment Outcome

Stephen L. Huhn, Gayatry Mohapatra, Andrew Bollen, Kathleen Lamborn, Michael D. Prados, Burt G. Feuerstein
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (6): 1435–1443.
Published: 01 June 1999
View article titled, Chromosomal Abnormalities in Glioblastoma Multiforme by Comparative Genomic Hybridization: Correlation with Radiation Treatment Outcome
Open the PDF for Chromosomal Abnormalities in Glioblastoma Multiforme by Comparative Genomic Hybridization: Correlation with Radiation Treatment Outcome in another window